/Companies

Myota

Blue Bell, US · Delaware corporation · 2 known investors

Find your way into Myota

1,127 people in our graph can introduce you to the Myota team.

Sign up to see every warm intro you have to Myota

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Myota team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Myota makes prebiotic fibre supplements that blend multiple clinically tested fibre sources into a daily scoop to support gut microbiome health, blood sugar control, cholesterol, digestion, and cognitive function. Sold direct to consumers, the products include a general blend and a "Sensitive" low-FODMAP formulation for people with digestive issues.

Founders & leadership

TGThomas Gurry
Thomas GurryCo-founder (microbiome scientist)Thomas Gurry is a computational and systems biologist who co-founded Myota, which develops prebiotic fibre supplements designed to support gut microbiome health and related outcomes including blood sugar control and digestion.
CHCaitlin Hall
Caitlin HallCo-founder (microbiome scientist)Caitlin Hall holds a PhD in neuroscience and is a registered dietitian in the UK and Australia with expertise in the gut microbiome–brain axis. As R&D Director at Myota, she oversees the clinical research program for the company's prebiotic fiber supplement line.
GGGabriel Gumbs
Gabriel GumbsExecutiveGabriel Gumbs leads Myota, which produces prebiotic fibre supplements for gut health and microbiome support. He has over 20 years of experience in technology and is a public speaker and co-host of the Privacy Please Podcast.
SS
Sergey SlipenchukExecutive
JC
James C. WalkerExecutive
SK
Samuel KouryNamed on SEC filing
SA
Stephen A. TullmanNamed on SEC filing
NW
Neal WalkerNamed on SEC filing

Board

IM
Ira M. LubertBoard director
JW
Jo WebberBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$15.7M disclosed across 6 rounds · 2018–2026

▶$3MraisedFeb 2026 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ira M. LubertDirector
  • Jo WebberDirector
  • Gabriel GumbsExecutive Officer
  • Sergey SlipenchukExecutive Officer
  • James C. WalkerExecutive Officer
Offering amount
$3M
Amount sold
$3M
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedApr 2025 · 16 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gabriel GumbsExecutive Officer
  • Neal WebberDirector
  • Jo WebberDirector
  • Sergey SlipenchukExecutive Officer
  • Ira M. LubertDirector
  • James C. WalkerExecutive Officer
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedMar 2024 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neal WalkerDirector
  • Gabriel GumbsExecutive Officer
  • Ira M. LubertDirector
  • Sergey SlipenchukExecutive Officer
  • Jo WebberDirector
  • James C WalkerExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2.3M
Proceeds to insiders
$668.5K
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$985KraisedMay 2023 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • James C WalkerExecutive Officer, Director
  • Sergey SlipenchukExecutive Officer
  • Ira M. LubertDirector
  • Neal WalkerDirector
  • Jo WebberDirector
Offering amount
$1M
Amount sold
$985K
Proceeds to insiders
$110K
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.8MraisedJun 2021 · 33 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES WALKERExecutive Officer, Director
  • SERGEY SLIPENCHUKExecutive Officer
  • A. STEPHEN WRAYExecutive Officer, Director
  • JO WEBBERDirector
  • NEAL WALKERDirector
  • IRA LUBERTDirector
Offering amount
$6M
Amount sold
$5.8M
Proceeds to insiders
$270K
First sale
May 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedMay 2018 · 46 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samuel KouryExecutive Officer, Director
  • Stephen A. TullmanDirector
  • James WalkerExecutive Officer, Director
  • Neal WalkerDirector
  • Sergey SlipenchukExecutive Officer
Offering amount
$2.1M
Amount sold
$2.1M
Proceeds to insiders
$200K
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as Myota.

Frequently asked questions

What does Myota do?
Myota makes prebiotic fibre supplements that blend multiple clinically tested fibre sources into a daily scoop to support gut microbiome health, blood sugar control, cholesterol, digestion, and cognitive function. Sold direct to consumers, the products include a general blend and a "Sensitive" low-FODMAP formulation for people with digestive issues.
Who founded Myota?
Myota was founded by Thomas Gurry, Caitlin Hall.
Who are Myota's investors?
Myota's investors include FoodLabs, PeakBridge VC.
How much funding has Myota raised?
Myota has disclosed $15.7M raised across 6 rounds.
Where is Myota headquartered?
Myota is headquartered in Blue Bell, US.